1. Nanog in iPS cells and during reprogramming
   Camila Vazquez Echegaray et al, 2022, Molecular Players in iPSC Technology CrossRef
2. Quercetin reduces pluripotency, migration and adhesion of human teratocarcinoma cell line NT2/D1 by inhibiting Wnt/β-catenin signaling
   Marija Mojsin et al, 2014, Food Funct. CrossRef
3. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer
   Ning Li et al, 2015, Medical Oncology CrossRef
4. The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers
   Shigeo Saito et al, 2021, Recent Advances in iPSC Technology CrossRef
5. Translational models of 3-D organoids and cancer stem cells in gastric cancer research
   Kenly Wuputra et al, 2021, Stem Cell Research & Therapy CrossRef
6. Nanog, as a key cancer stem cell marker in tumor progression
   Parisa Vasefifar et al, 2022, Gene CrossRef
7. The NANOG Transcription Factor Induces Type 2 Deiodinase Expression and Regulates the Intracellular Activation of Thyroid Hormone in Keratinocyte Carcinomas
   Annarita Nappi et al, 2020, Cancers CrossRef
8. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: A bioinformatic analysis combine with RNAi and oligonucleotide microarray
   QIPING HU et al, 2015, Oncology Reports CrossRef
9. The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway
   Ana Virginia Sánchez-Sánchez et al, 2021, International Journal of Molecular Sciences CrossRef
10. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions
    Collene R. Jeter et al, 2015, Stem Cells CrossRef
11. Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis
    Zeyaul Islam et al, 2021, Frontiers in Oncology CrossRef
12. The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells
    Dan-dan Xu et al, 2018, Frontiers in Pharmacology CrossRef
13. Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration
    Basira Najafzadeh et al, 2022, Pathology - Research and Practice CrossRef
14. The Prospects of RNAs and Common Significant Pathways in Cancer Therapy and Regenerative Medicine
    Manaswini Gattupalli et al, 2023, Regenerative Medicine CrossRef
15. DPPA2 Protein Expression is Associated with Gastric Cancer Metastasis
    Hoda Shabestarian et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
16. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer
    Chun Hu et al, 2016, Journal of Drug Targeting CrossRef
17. Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG
    Christina Wefers et al, 2018, Frontiers in Immunology CrossRef
18. Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil
    Neda Khosravi et al, 2021, European Journal of Pharmacology CrossRef
19. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors
    Julia A. Joselevitch et al, 2018, Veterinary Pathology CrossRef
20. Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells
    Masoumeh Es-haghi et al, 2016, Tumor Biology CrossRef
21. Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery
    Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
22. Interaction between gastric cancer stem cells and the tumor microenvironment
    Takatsugu Ishimoto et al, 2014, Journal of Gastroenterology CrossRef